Valuation Voyageur Pharmaceuticals Ltd.

Stocks

Market Closed - Toronto S.E. 07:12:36 21/08/2026 pm IST			5-day change	1st Jan Change
0.1550 ^CAD	-3.12%		-3.12%	-8.82%

10/08	Voyageur Pharmaceuticals Ltd. Advances Mueller Iodine Extraction Process with 99.8% Purity Results and Planned Field Pilot Testing	CI
25/07	Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: November	2020	2021	2022	2023	2024	2025
Market Cap ¹	2.855	9.164	8.025	5.308	9.066	28.55
Change	-	221.01%	-12.43%	-33.85%	70.79%	214.92%
Enterprise Value (EV) ¹	3.197	8.387	8.013	5.343	8.953	28.32
Change	-	162.35%	-4.46%	-33.32%	67.58%	216.31%
P/E	-2.48x	-4.15x	-4.3x	-3.73x	-5.24x	-7.5x
PBR	9.32x	4.81x	5.52x	3.7x	20.1x	22.8x
PEG	-	-0.1x	0.2x	0.1x	-0.3x	-0.1x
Capitalization / Revenue	-	-	-	-	-	2,44,33,11,938x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-3.25x	-4.25x	-5.02x	-4.38x	-5.92x	-9.79x
EV / EBIT	-2.81x	-4.25x	-4.99x	-4.37x	-5.91x	-9.79x
EV / FCF	-58.1x	-7.96x	-6.73x	-9.15x	14.8x	-17x
FCF Yield	-1.72%	-12.6%	-14.8%	-10.9%	6.74%	-5.89%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0162	-0.0217	-0.0163	-0.0107	-0.0124	-0.0213
Distribution rate	-	-	-	-	-	-
Net sales	-	-	-	-	-	0.0117
EBITDA ¹	-0.9846	-1.972	-1.596	-1.221	-1.513	-2.892
EBIT ¹	-1.138	-1.974	-1.605	-1.223	-1.515	-2.893
Net income ¹	-1.139	-2.051	-1.754	-1.399	-1.707	-3.533
Net Debt ¹	0.3422	-0.7768	-0.012	0.0344	-0.1126	-0.2306
Reference price ²	0.0400	0.0900	0.0700	0.0400	0.0650	0.1600
Nbr of stocks (in thousands)	71,366	1,01,820	1,14,638	1,32,702	1,39,473	1,78,438
Announcement Date	30/03/21	17/03/22	30/03/23	26/03/24	31/03/25	27/03/26

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VOYAGEUR PHARMACEUTICALS LTD.	-	-	-	-	2.55Cr
ELI LILLY AND COMPANY	35.74x	12.95x	26.26x	0.55%	1,11900Cr
JOHNSON & JOHNSON	30.06x	-	-	1.99%	65TCr
ABBVIE INC.	33.82x	7.82x	16.26x	2.59%	47TCr
ROCHE HOLDING AG	20.93x	4.96x	12.28x	2.66%	37TCr
NOVARTIS AG	22.59x	5.81x	14.4x	2.75%	30TCr
ASTRAZENECA PLC	21.37x	4.4x	12.49x	1.99%	26TCr
AMGEN INC.	27.79x	7.17x	12.73x	2.3%	24TCr
NOVO NORDISK A/S	13.71x	4.87x	10.23x	3.75%	21TCr
GILEAD SCIENCES, INC.	-44.65x	6.45x	25.18x	2.26%	18TCr
Average	17.93x	6.80x	16.23x	2.31%	38TCr
Weighted average by Cap.	25.51x	8.51x	18.70x	1.89%